BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yamaoka-Tojo M. Vascular Endothelial Glycocalyx Damage in COVID-19. Int J Mol Sci 2020;21:E9712. [PMID: 33352699 DOI: 10.3390/ijms21249712] [Cited by in Crossref: 39] [Cited by in F6Publishing: 33] [Article Influence: 19.5] [Reference Citation Analysis]
Number Citing Articles
1 Koutsiaris AG, Riri K, Boutlas S, Panagiotou TN, Kotoula M, Daniil Z, Tsironi EE. COVID-19 hemodynamic and thrombotic effect on the eye microcirculation after hospitalization: A quantitative case-control study. CH 2022. [DOI: 10.3233/ch-221554] [Reference Citation Analysis]
2 Masola V, Greco N, Gambaro G, Franchi M, Onisto M. Heparanase as active player in endothelial glycocalyx remodeling. Matrix Biol Plus 2022;13:100097. [PMID: 35036899 DOI: 10.1016/j.mbplus.2021.100097] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
3 Tanaka A, Node K. Collective Knowledge Used to Unveil Cardiovascular Injury Emerged during COVID-19. Int J Mol Sci 2022;23:5178. [PMID: 35563569 DOI: 10.3390/ijms23095178] [Reference Citation Analysis]
4 Zha D, Fu M, Qian Y. Vascular Endothelial Glycocalyx Damage and Potential Targeted Therapy in COVID-19. Cells 2022;11:1972. [PMID: 35741101 DOI: 10.3390/cells11121972] [Reference Citation Analysis]
5 Ballermann BJ, Nyström J, Haraldsson B. The Glomerular Endothelium Restricts Albumin Filtration. Front Med (Lausanne) 2021;8:766689. [PMID: 34912827 DOI: 10.3389/fmed.2021.766689] [Reference Citation Analysis]
6 Feng F, Chen J, Zhao J, Li Y, Li M, Sun C. Killing Two Birds with One Stone by Administration of Soluble ACE2: A Promising Strategy to Treat Both Cardiovascular Diseases and SARS-CoV-2 Infection. Viruses 2021;13:2243. [PMID: 34835049 DOI: 10.3390/v13112243] [Reference Citation Analysis]
7 Rejinold NS, Piao H, Jin GW, Choi G, Choy JH. Injectable niclosamide nanohybrid as an anti-SARS-CoV-2 strategy. Colloids Surf B Biointerfaces 2021;208:112063. [PMID: 34482191 DOI: 10.1016/j.colsurfb.2021.112063] [Reference Citation Analysis]
8 Beltrán-camacho L, Eslava-alcón S, Rojas-torres M, Sánchez-morillo D, Martinez-nicolás MP, Martín-bermejo V, de la Torre IG, Berrocoso E, Moreno JA, Moreno-luna R, Durán-ruiz MC. The serum of COVID-19 asymptomatic patients up-regulates proteins related to endothelial dysfunction and viral response in circulating angiogenic cells ex-vivo. Mol Med 2022;28. [DOI: 10.1186/s10020-022-00465-w] [Reference Citation Analysis]
9 Taşkin Ö, Yilmaz A, Soylu VG, Demir U, Kurada G. POSTERIOR REVERSIBL ENCEPHALOPATHY SYNDROME IN COVID 19 DISEASE: A RARE CASE. Journal of Emergency Medicine Case Reports. [DOI: 10.33706/jemcr.1022869] [Reference Citation Analysis]
10 Almahayni K, Spiekermann M, Fiore A, Yu G, Pedram K, Möckl L. Small molecule inhibitors of mammalian glycosylation. Matrix Biology Plus 2022. [DOI: 10.1016/j.mbplus.2022.100108] [Reference Citation Analysis]
11 Baltrūnas T, Račytė A, Pikturnaitė G, Skrebūnas A, Vaišnytė B. Aortic thrombosis after DVT and PE in a young COVID-19 patient. Ann Vasc Surg 2021:S0890-5096(21)00498-2. [PMID: 34411673 DOI: 10.1016/j.avsg.2021.07.005] [Reference Citation Analysis]
12 Tricarico G, Travagli V. COVID-19: Precision Medicine and Vascular Endothelium. Mayo Clin Proc 2021;96:1672. [PMID: 34088423 DOI: 10.1016/j.mayocp.2021.04.004] [Reference Citation Analysis]
13 O Ercelen N, Pekkoc-Uyanik KC, Alpaydin N, Gulay GR, Simsek M. Clinical experience on umbilical cord mesenchymal stem cell treatment in 210 severe and critical COVID-19 cases in Turkey. Stem Cell Rev Rep 2021. [PMID: 34319510 DOI: 10.1007/s12015-021-10214-x] [Reference Citation Analysis]
14 du Preez HN, Aldous C, Hayden MR, Kruger HG, Lin J. Pathogenesis of COVID-19 described through the lens of an undersulfated and degraded epithelial and endothelial glycocalyx. FASEB J 2022;36:e22052. [PMID: 34862979 DOI: 10.1096/fj.202101100RR] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 De Pasquale V, Quiccione MS, Tafuri S, Avallone L, Pavone LM. Heparan Sulfate Proteoglycans in Viral Infection and Treatment: A Special Focus on SARS-CoV-2. Int J Mol Sci 2021;22:6574. [PMID: 34207476 DOI: 10.3390/ijms22126574] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
16 Shinkai W, Hashikata T, Kameda R, Sato N, Minami Y, Ako J. Very late stent thrombosis lacking findings of the typical causes on optical coherence tomography in a patient with SARS-CoV-2. J Cardiol Cases 2022. [PMID: 35572350 DOI: 10.1016/j.jccase.2022.04.011] [Reference Citation Analysis]
17 Rejinold N S, Choi G, Piao H, Choy JH. Bovine Serum Albumin-Coated Niclosamide-Zein Nanoparticles as Potential Injectable Medicine against COVID-19. Materials (Basel) 2021;14:3792. [PMID: 34300711 DOI: 10.3390/ma14143792] [Reference Citation Analysis]
18 Abdelmassih Y, Azar G, Bonnin S, Scemama Timsit C, Vasseur V, Spaide RF, Behar-Cohen F, Mauget-Faysse M. COVID-19 Associated Choroidopathy. J Clin Med 2021;10:4686. [PMID: 34682810 DOI: 10.3390/jcm10204686] [Reference Citation Analysis]
19 Fels B, Acharya S, Vahldieck C, Graf T, Käding N, Rupp J, Kusche-Vihrog K. Mineralocorticoid receptor-antagonism prevents COVID-19-dependent glycocalyx damage. Pflugers Arch 2022. [PMID: 35867189 DOI: 10.1007/s00424-022-02726-3] [Reference Citation Analysis]
20 Masola V, Zaza G, Arduini A, Onisto M, Gambaro G. Endothelial Glycocalyx as a Regulator of Fibrotic Processes. Int J Mol Sci 2021;22:2996. [PMID: 33804258 DOI: 10.3390/ijms22062996] [Reference Citation Analysis]
21 Qu J, Cheng Y, Wu W, Yuan L, Liu X. Glycocalyx Impairment in Vascular Disease: Focus on Inflammation. Front Cell Dev Biol 2021;9:730621. [PMID: 34589494 DOI: 10.3389/fcell.2021.730621] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Tricarico G, Travagli V. Approach to the management of COVID-19 patients: When home care can represent the best practice. Int J Risk Saf Med 2022. [PMID: 35786662 DOI: 10.3233/JRS-210064] [Reference Citation Analysis]
23 Melkumyants A, Buryachkovskaya L, Lomakin N, Antonova O, Docenko J, Ermishkin V, Serebruany V. Effect of Sulodexide on Circulating Blood Cells in Patients with Mild COVID-19. JCM 2022;11:1995. [DOI: 10.3390/jcm11071995] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Hoteit L, Deeb AP, Andraska EA, Kaltenmeier C, Yazdani HO, Tohme S, Neal MD, Mota RI. The Pathobiological Basis for Thrombotic Complications in COVID-19: a Review of the Literature. Curr Pathobiol Rep 2021;:1-11. [PMID: 34900401 DOI: 10.1007/s40139-021-00228-y] [Reference Citation Analysis]
25 Nia AM, Srinivasan VM, Hayworth MK, Lall RR, Kan P. A History of Cerebrovascular Disease Is Independently Associated with Increased Morbidity and Mortality in Patients with COVID-19: A Cohort Study of 369,563 COVID-19 Cases in the USA. Cerebrovasc Dis 2021;:1-9. [PMID: 34515073 DOI: 10.1159/000517499] [Reference Citation Analysis]
26 Vollenberg R, Tepasse PR, Ochs K, Floer M, Strauss M, Rennebaum F, Kabar I, Rovas A, Nowacki T. Indications of Persistent Glycocalyx Damage in Convalescent COVID-19 Patients: A Prospective Multicenter Study and Hypothesis. Viruses 2021;13:2324. [PMID: 34835130 DOI: 10.3390/v13112324] [Reference Citation Analysis]
27 Shimizu M, Hashimoto S. Peripheral oxygen saturation to inspiratory oxygen fraction ratio-based identification of critically ill coronavirus disease patients for early therapeutic interventions. J Anesth 2021. [PMID: 34392404 DOI: 10.1007/s00540-021-02986-w] [Reference Citation Analysis]
28 Block MS. Coronavirus Disease 2019 May Affect Dental Implant Integration. J Oral Maxillofac Surg 2021;79:1197-8. [PMID: 33667347 DOI: 10.1016/j.joms.2021.01.033] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
29 Maruhashi T, Higashi Y. Pathophysiological Association of Endothelial Dysfunction with Fatal Outcome in COVID-19. Int J Mol Sci 2021;22:5131. [PMID: 34066226 DOI: 10.3390/ijms22105131] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
30 Wautier J, Wautier M. Vascular Permeability in Diseases. IJMS 2022;23:3645. [DOI: 10.3390/ijms23073645] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
31 Lallana S, Chen A, Requena M, Rubiera M, Sanchez A, Siegler JE, Muchada M. Posterior reversible encephalopathy syndrome (PRES) associated with COVID-19. J Clin Neurosci 2021;88:108-12. [PMID: 33992168 DOI: 10.1016/j.jocn.2021.03.028] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
32 Kuśnierz-Cabala B, Maziarz B, Dumnicka P, Dembiński M, Kapusta M, Bociąga-Jasik M, Winiarski M, Garlicki A, Grodzicki T, Kukla M. Diagnostic Significance of Serum Galectin-3 in Hospitalized Patients with COVID-19-A Preliminary Study. Biomolecules 2021;11:1136. [PMID: 34439802 DOI: 10.3390/biom11081136] [Reference Citation Analysis]
33 Schenck H, Netti E, Teernstra O, De Ridder I, Dings J, Niemelä M, Temel Y, Hoogland G, Haeren R. The Role of the Glycocalyx in the Pathophysiology of Subarachnoid Hemorrhage-Induced Delayed Cerebral Ischemia. Front Cell Dev Biol 2021;9:731641. [PMID: 34540844 DOI: 10.3389/fcell.2021.731641] [Reference Citation Analysis]
34 Veluswamy P, Wacker M, Stavridis D, Reichel T, Schmidt H, Scherner M, Wippermann J, Michels G. The SARS-CoV-2/Receptor Axis in Heart and Blood Vessels: A Crisp Update on COVID-19 Disease with Cardiovascular Complications. Viruses 2021;13:1346. [PMID: 34372552 DOI: 10.3390/v13071346] [Reference Citation Analysis]